United Therapeutics Corpo...

NASDAQ: UTHR · Real-Time Price · USD
312.86
0.80 (0.26%)
At close: Aug 15, 2025, 3:59 PM
313.13
0.09%
After-hours: Aug 15, 2025, 05:27 PM EDT

United Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
1.2B 984.8M 727.3M 475.8M
Depreciation & Amortization
72.5M 53.2M 51.3M 49.9M
Stock-Based Compensation
144M 39.1M 106.8M 138.5M
Other Working Capital
-55.6M -82.8M -150.6M -112.9M
Other Non-Cash Items
-24.3M -1.3M 23.9M 72.5M
Deferred Income Tax
n/a n/a -71.7M -89.7M
Change in Working Capital
-60.2M -97.8M -35.1M -48.8M
Operating Cash Flow
1.33B 978M 802.5M 598.2M
Capital Expenditures
-246.5M -230.4M -138.8M -120.8M
Cash Acquisitions
n/a -89.2M 7.1M 366.1M
Purchase of Investments
-1.65B -2.51B -1.71B -1.9B
Sales Maturities Of Investments
2.37B 2.14B 1.03B 1.53B
Other Investing Acitivies
-59M -23M 3.5M -366.1M
Investing Cash Flow
417.2M -719.6M -811.5M -486.9M
Debt Repayment
-400M -100M n/a n/a
Common Stock Repurchased
-1.01B -13.8M -11.4M -10.8M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
157.4M 101.9M 86.8M 55.6M
Financial Cash Flow
-1.25B -11.9M 75.4M 44.8M
Net Cash Flow
489.5M 246.5M 66.4M 156.1M
Free Cash Flow
1.08B 747.6M 663.7M 477.4M